Biofrontera Analyst Ratings
Biofrontera Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/31/2023 | 677.78% | Benchmark | $11 → $7 | Reiterates | → Buy |
| 12/15/2021 | 1122.22% | Benchmark | → $11 | Initiates Coverage On | → Buy |
| 11/24/2021 | 2122.22% | Roth Capital | → $20 | Initiates Coverage On | → Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 01/31/2023 | 677.78% | 基準 | 十一美元 → 7 美元 | 重申 | → 購買 |
| 12/15/2021 | 1122.22% | 基準 | → 11 美元 | 啟動覆蓋範圍 | → 購買 |
| 11/24/2021 | 2122.22% | 羅斯資本 | → 20 美元 | 啟動覆蓋範圍 | → 購買 |
What is the target price for Biofrontera (BFRI)?
生物弗龍特拉 (BFRI) 的目標價格是多少？
The latest price target for Biofrontera (NASDAQ: BFRI) was reported by Benchmark on January 31, 2023. The analyst firm set a price target for $7.00 expecting BFRI to rise to within 12 months (a possible 677.78% upside). 1 analyst firms have reported ratings in the last year.
Biofrontera（納斯達克股票代碼：BFRI）的最新價格目標已於 2023 年 1 月 31 日公佈。該分析師公司設定了 7.00 美元的價格目標，預計 BFRI 將在 12 個月內上升至（可能有 677.78％ 的上漲情況）。去年有 1 家分析師公司報告了評級。
What is the most recent analyst rating for Biofrontera (BFRI)?
生物弗龍特拉 (BFRI) 的最新分析師評級為何？
The latest analyst rating for Biofrontera (NASDAQ: BFRI) was provided by Benchmark, and Biofrontera reiterated their speculative buy rating.
Biofrontera（納斯達克股票代碼：BFRI）的最新分析師評級由基準提供，Biofrontera 重申了他們的投機性買入評級。
When is the next analyst rating going to be posted or updated for Biofrontera (BFRI)?
Biofrontera（BFRI）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biofrontera, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biofrontera was filed on January 31, 2023 so you should expect the next rating to be made available sometime around January 31, 2024.
分析師在進行廣泛的研究後到達股票評級，其中包括通過公共財務報表，與 Biofrontera 的高管和客戶交談以及收聽盈利電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。Biofrontera 的最後評級已於 2023 年 1 月 31 日提交，因此您應該期望下一個評分將在 2024 年 1 月 31 日左右的某個時間提供。
Is the Analyst Rating Biofrontera (BFRI) correct?
分析師評級生物福隆特拉（BFRI）是否正確？
While ratings are subjective and will change, the latest Biofrontera (BFRI) rating was a reiterated with a price target of $11.00 to $7.00. The current price Biofrontera (BFRI) is trading at is $0.90, which is out of the analyst's predicted range.
儘管評級是主觀的並且會發生變化，但最新的 BFRI 評級重申了目標價格為 11.00 美元至 7.00 美元。目前的價格比奧弗隆特拉（BFRI）的交易價格為 0.90 美元，超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。